1st Edition

Approaches to the Conformational Analysis of Biopharmaceuticals

By Roger L. Lundblad Copyright 2010
368 Pages 41 B/W Illustrations
by Chapman & Hall

368 Pages 41 B/W Illustrations
by Chapman & Hall

366 Pages
by Chapman & Hall

The activity of many biopharmaceutical polymers is dependent on conformation, and the next several years will see increased interest in the conformational analysis of these polymers resulting from the development of biosimilar or "follow-on" biological products. While a wide variety of approaches to analysis exists, finding the most viable ones would be much easier with a consolidated reference... Read more

Introduction to Biopharmaceutical Conformational Analysis: Issues and Methods

Comparability of Biotechnological/Biological Products and Biological Generics

Application of Native Electrophoresis for the Study of Protein Conformation

Affinity Chromatography Including Hydrophobic Interaction

Chromatography in the Study of Biopolymer Conformation

Size-Exclusion Chromatography and Biomolecular Conformation

Use of Analytical Ultracentrifugation to Study Biomolecular Conformation

Use of Differential Scanning Calorimetry to Measure Conformational Change in Proteins and Other Biomacromolecules

Light Scattering and Biomacromolecular Conformation

Use of Luminescence to Measure Conformational Change in Biopharmaceuticals with Emphasis on Protein and Protein Drug Products

Near-Infrared Spectroscopy and Macromolecular Conformation

The Use of Mid-Infrared and Fourier Transform Infrared Spectroscopy to Study Conformation of Biomacromolecules

Use of Raman Spectroscopy to Evaluate Biopharmaceutical Conformation

Use of UV-VIS Spectrophotometry for the Characterization of Biopharmaceutical Products

Use of Optical Rotatory Dispersion and Circular Dichroism to Study Therapeutic Biomacromolecule Conformation

Use of Nuclear Magnetic Resonance for the Characterization of Biotherapeutic Products

Use of Chemical Probes for the Study of Protein Conformation

Use of Hydrogen Exchange in the Study of Biopharmaceutical Conformation

Use of Chemical Modification for the Conformational Analysis of Biopharmaceuticals

Use of Immunology to Characterize Biopharmaceutical Conformation

Use of Limited Proteolysis to Study the Conformation of Proteins of Biotechnology Interest

Other Technologies for the Characterization of Conformational Change in Biopharmaceuticals

Development of an Experimental Approach for the Study of the Conformation of a Biological Therapeutic Product

Biography

After postdoctoral work at Rockefeller University, New York, Dr. Roger L. Lundblad joined the faculty of the University of North Carolina at Chapel Hill in 1968. He joined the Hyland division of Baxter Healthcare in 1990. Currently, he is an independent consultant and biotechnology writer based in Chapel Hill, North Carolina. He is an adjunct professor of pathology at the University of North Carolina at Chapel Hill and an editor in chief of the Internet Journal of Genomics and Proteomics.

"Lundblad (pathology, U. of North Carolina at Chapel Hill) provides coverage of the range of technology used for the conformational analysis of biopharmaceutical polymers, intending to provide sufficient information and extensive references to establish the basis for the selection of a specific experimental approach that would be most cost-effective in the study of biopolymer conformation. Technologies addressed include native electrophoresis, affinity chromatography, size-exclusion chromatography, analytical ultracentrifugation, differential scanning calorimetry, light scattering, luminescence, near-infrared spectroscopy, mid-infrared and Fourier transform infrared spectroscopy, Raman spectroscopy, UV-VIS spectroscopy, optical rotatory dispersion and circular dichroism, nuclear magnetic resonance, chemical probes, hydrogen exchange, chemical modification,. immunology, and limited proteolysis"
2010 Book News Inc., Portland, Oregon

"Without any hesitation, I recommend this book to any researcher involved in the analysis of conformation and stability of biotechnology products (not necessarily limited to biopharmaceuticals)."
—Igor A Kaltashov. Future Science